詞庫查詢
查詢 Elsevier TF-IDF 關鍵詞（16,935 詞）與 THU 中文擴充詞庫。想知道自己的研究會命中哪些規則？先查這裡。
Elsevier TF-IDF 詞 16,935 筆
| SDG | 目標 | 詞 | 集合內文獻 | Scopus 文獻 | 佔比 | TF-IDF |
|---|---|---|---|---|---|---|
| 3 | 良好健康與福祉 | extrathyroidal extension |
1,383 | 1,451 | 95% | 19.25 |
| 3 | 良好健康與福祉 | epidermal growth factor receptor mutation |
1,332 | 1,391 | 96% | 19.25 |
| 3 | 良好健康與福祉 | and cancer therapy |
1,838 | 1,979 | 93% | 19.25 |
| 3 | 良好健康與福祉 | tb diagnosis |
2,112 | 2,288 | 92% | 19.25 |
| 3 | 良好健康與福祉 | usual interstitial pneumonia |
1,795 | 1,930 | 93% | 19.25 |
| 3 | 良好健康與福祉 | cancer registry data |
2,404 | 2,610 | 92% | 19.25 |
| 3 | 良好健康與福祉 | human prostate cancer cell line |
1,844 | 1,986 | 93% | 19.25 |
| 3 | 良好健康與福祉 | hev infection |
2,074 | 2,246 | 92% | 19.25 |
| 3 | 良好健康與福祉 | human hepatocellular carcinoma cell |
2,518 | 2,734 | 92% | 19.25 |
| 3 | 良好健康與福祉 | hereditary breast and ovarian cancer |
1,436 | 1,514 | 95% | 19.25 |
| 3 | 良好健康與福祉 | methicillin-resistant s. aureus (mrsa) |
2,854 | 3,092 | 92% | 19.25 |
| 3 | 良好健康與福祉 | clinicopathologic factors |
2,744 | 2,976 | 92% | 19.25 |
| 3 | 良好健康與福祉 | prostate cancer screening |
2,566 | 2,786 | 92% | 19.25 |
| 3 | 良好健康與福祉 | chronic kidney disease epidemiology collaboration |
1,269 | 1,317 | 96% | 19.25 |
| 3 | 良好健康與福祉 | antiretroviral medication |
1,626 | 1,736 | 94% | 19.25 |
| 3 | 良好健康與福祉 | symptomatic intracranial hemorrhage |
1,576 | 1,678 | 94% | 19.25 |
| 3 | 良好健康與福祉 | endovascular thrombectomy |
1,521 | 1,614 | 94% | 19.25 |
| 3 | 良好健康與福祉 | melanoma progression |
2,050 | 2,220 | 92% | 19.25 |
| 3 | 良好健康與福祉 | programmed death-ligand 1 |
3,125 | 3,375 | 93% | 19.25 |
| 3 | 良好健康與福祉 | panitumumab |
1,885 | 2,034 | 93% | 19.25 |
| 3 | 良好健康與福祉 | early-stage breast cancer |
4,366 | 4,596 | 95% | 19.25 |
| 3 | 良好健康與福祉 | carcinoma hepatocellular |
3,284 | 3,538 | 93% | 19.25 |
| 3 | 良好健康與福祉 | programmed cell death protein 1 |
2,475 | 2,689 | 92% | 19.25 |
| 3 | 良好健康與福祉 | papillary thyroid carcinoma (ptc) |
4,280 | 4,515 | 95% | 19.25 |
| 3 | 良好健康與福祉 | cancer gene expression |
2,266 | 2,461 | 92% | 19.25 |
| 3 | 良好健康與福祉 | type 1 and type 2 diabetes |
3,937 | 4,187 | 94% | 19.25 |
| 3 | 良好健康與福祉 | oscc cells |
1,676 | 1,795 | 93% | 19.25 |
| 3 | 良好健康與福祉 | hiv rna level |
1,253 | 1,299 | 96% | 19.25 |
| 3 | 良好健康與福祉 | diabetes prevention program |
1,361 | 1,427 | 95% | 19.25 |
| 3 | 良好健康與福祉 | incident cvd |
1,279 | 1,330 | 96% | 19.25 |
| 3 | 良好健康與福祉 | immunosuppressive tumor microenvironment |
1,526 | 1,621 | 94% | 19.25 |
| 3 | 良好健康與福祉 | long-acting reversible |
1,635 | 1,748 | 94% | 19.25 |
| 3 | 良好健康與福祉 | advanced rectal cancer |
4,136 | 4,380 | 94% | 19.25 |
| 3 | 良好健康與福祉 | epidermal growth factor receptor tyrosine kinase inhibitor |
1,579 | 1,683 | 94% | 19.25 |
| 3 | 良好健康與福祉 | overall and disease-free survival |
2,582 | 2,806 | 92% | 19.25 |
| 3 | 良好健康與福祉 | mother-to-child transmission of hiv |
1,615 | 1,725 | 94% | 19.25 |
| 3 | 良好健康與福祉 | rectal cancer surgery |
3,571 | 3,829 | 93% | 19.25 |
| 3 | 良好健康與福祉 | progression-free survival rate |
2,133 | 2,315 | 92% | 19.25 |
| 3 | 良好健康與福祉 | 5-year dfs |
1,594 | 1,701 | 94% | 19.25 |
| 3 | 良好健康與福祉 | cancer phenotype |
2,080 | 2,256 | 92% | 19.25 |
| 3 | 良好健康與福祉 | nk/t-cell |
1,356 | 1,422 | 95% | 19.25 |
| 3 | 良好健康與福祉 | ncdb |
1,636 | 1,750 | 93% | 19.25 |
| 3 | 良好健康與福祉 | asthma children |
2,839 | 3,081 | 92% | 19.25 |
| 3 | 良好健康與福祉 | neoadjuvant chemotherapy. |
3,491 | 3,751 | 93% | 19.25 |
| 3 | 良好健康與福祉 | multikinase inhibitor |
1,763 | 1,897 | 93% | 19.25 |
| 3 | 良好健康與福祉 | human hepatocellular carcinoma (hcc) |
1,940 | 2,099 | 92% | 19.25 |
| 3 | 良好健康與福祉 | pre-exposure prophylaxis (prep) |
3,114 | 3,368 | 92% | 19.25 |
| 3 | 良好健康與福祉 | sy5y neuroblastoma |
2,008 | 2,176 | 92% | 19.25 |
| 3 | 良好健康與福祉 | human colorectal cancer cells |
1,402 | 1,477 | 95% | 19.25 |
| 3 | 良好健康與福祉 | svr12 |
1,266 | 1,316 | 96% | 19.25 |